DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs
We previously developed optimized DNA vaccines against both Lassa fever and Ebola hemorrhagic fever viruses and demonstrated that they were protective individually in guinea pig and nonhuman primate models. In this study, we vaccinated groups of strain 13 guinea pigs two times, four weeks apart with...
Saved in:
Main Authors: | Kathleen A. Cashman (Author), Eric R. Wilkinson (Author), Suzanne E. Wollen (Author), Joshua D. Shamblin (Author), Justine M. Zelko (Author), Jeremy J. Bearss (Author), Xiankun Zeng (Author), Kate E. Broderick (Author), Connie S. Schmaljohn (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
by: Kathleen A. Cashman, et al.
Published: (2017) -
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
by: Jingjing Jiang, et al.
Published: (2019) -
A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
by: David Safronetz, et al.
Published: (2015) -
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
by: Xiangguo Qiu, et al.
Published: (2012) -
Electrophysiological and Pharmacological Characteristics of Triggered Activity Elicited in Guinea-Pig Pulmonary Vein Myocardium
by: Akira Takahara, et al.
Published: (2011)